Strategies to defeat ketamine-induced neonatal brain injury

Neuroscience

Volumn 210, Issue , 2012, Pages 384-392

  Turner, C P ^a   Gutierrez, S ^a   Liu, C ^a   Miller, L ^a   Chou, J ^a   Finucane, B ^a   Carnes, A ^a   Kim, J ^a   Shing, E ^a   Haddad, T ^a   Phillips, A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthesia; Cell death; Glutamate; Neonatal; Prevention; Rat

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CASPASE 3; CASPASE 3; COLECALCIFEROL; DAVUNETIDE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ACTIVITY DEPENDENT NEUROPROTECTIVE PEPTIDE GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETROSPLENIAL CORTEX; SOMATOSENSORY CORTEX;

ANESTHETICS, DISSOCIATIVE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KETAMINE; MALE; MICROARRAY ANALYSIS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSENSORY CORTEX;

EID: 84862776510     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.02.015     Document Type: Article

References (61)

1. Asimiadou S., Bittigau P., Felderhoff-Mueser U., Manthey D., Sifringer M., Pesditschek S., Dzietko M., Kaindl A.M., Pytel M., Studniarczyk D., Mozrzymas J.W., Ikonomidou C. Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol 2005, 58:266-276.
2. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 1999, 72:1283-1293.
3. Berger C., Xia F., Schabitz W.R., Schwab S., Grau A. High-dose aspirin is neuroprotective in a rat focal ischemia model. Brain Res 2004, 998:237-242.
4. Cattano D., Valleggi S., Ma D., Kastsiuchenka O., Abramo A., Sun P., Cavazzana A.O., Natale G., Maze M., Giunta F. Xenon induces transcription of ADNP in neonatal rat brain. Neurosci Lett 2008, 440:217-221.
5. Chou J.W., Zhou T., Kaufmann W.K., Paules R.S., Bushel P.R. Extracting gene expression patterns and identifying co-expressed genes from microarray data reveals biologically responsive processes. BMC Bioinform 2007, 8:427.
6. Clancy B., Darlington R.B., Finlay B.L. Translating developmental time across mammalian species. Neuroscience 2001, 105:7-17.
7. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
8. Clancy B., Kersh B., Hyde J., Darlington R.B., Anand K.J., Finlay B.L. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007, 5:79-94.
9. de Graaf-Peters V.B., Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when?. Early Hum Dev 2006, 82:257-266.
10. Ditsworth D., Priestley M.A., Loepke A.W., Ramamoorthy C., McCann J., Staple L., Kurth C.D. Apoptotic neuronal death following deep hypothermic circulatory arrest in piglets. Anesthesiology 2003, 98:1119-1127.
11. Flick R.P., Katusic S.K., Colligan R.C., Wilder R.T., Voigt R.G., Olson M.D., Sprung J., Weaver A.L., Schroeder D.R., Warner D.O. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011, 128(5):e1053-e1061.
12. Gidday J.M., Fitzgibbons J.C., Shah A.R., Park T.S. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994, 168:221-224.
13. Gozes I. Activity-dependent neuroprotective protein: from gene to drug candidate. Pharmacol Ther 2007, 114:146-154.
14. Gozes I., Divinski I. NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Curr Alzheimer Res 2007, 4:507-509.
15. Gozes I., Divinski I., Piltzer I. NAP and d-SAL: neuroprotection against the beta amyloid peptide (1-2). BMC Neurosci 2008, 9(Suppl 3):S3.
16. Gutierrez S., Carnes A., Finucane B., Musci G., Oelsner W., Hicks L., Russell G.B., Liu C., Turner C.P. Is age-dependent, ketamine-induced apoptosis in the rat somatosensory cortex influenced by temperature?. Neuroscience 2010, 168:253-262.
17. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., Wang K.K. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J Neurosci 1995, 15:4093-4101.
18. Hossain M.A., Russell J.C., O'Brien R., Laterra J. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. J Neurosci 2004, 24:4187-4196.
19. Idan-Feldman A., Schirer Y., Polyzoidou E., Touloumi O., Lagoudaki R., Grigoriadis N.C., Gozes I. Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. Neurobiol Dis 2011, 44:327-339.
20. Ikonomidou C., Mosinger J.L., Olney J.W. Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant rats. Brain Res 1989, 487:184-187.
21. Jehle T., Dimitriu C., Auer S., Knoth R., Vidal-Sanz M., Gozes I., Lagrèze W.A. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 2008, 246:1255-1263.
22. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003, 23:876-882.
23. Joly L.M., Mucignat V., Mariani J., Plotkine M., Charriaut-Marlangue C. Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 2004, 24:124-131.
24. Kumral A., Yesilirmak D.C., Sonmez U., Baskin H., Tugyan K., Yilmaz O., Genc S., Gokmen N., Genc K., Duman N., Ozkan H. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res 2006, 1115:169-178.
25. Lema Tomé C.M., Bauer C., Nottingham C., Smith C., Blackstone K., Brown L., Hlavaty C., Nelson C., Daker R., Sola R., Miller R., Bryan R., Turner C.P. MK801-induced caspase-3 in the postnatal brain: inverse relationship with calcium binding proteins. Neuroscience 2006, 141:1351-1363.
26. Lema Tomé C.M., Miller R., Bauer C., Nottingham C., Smith C., Blackstone K., Brown L., Bryan R., Leigh A., Brady M., Busch J., Turner C.P. Decline in age-dependent, MK801-induced injury coincides with developmental switch in parvalbumin expression: cingulate and retrosplenial cortex. Dev Psychobiol 2007, 49:606-618.
27. Lema Tomé C.M., Miller R., Bauer C., Smith C., Blackstone K., Leigh A., Busch J., Turner C.P. Decline in age-dependent, MK801-induced injury coincides with developmental switch in parvalbumin expression: somatosensory and motor cortex. Dev Psychobiol 2008, 50:665-679.
28. Lema Tomé C.M., Nottingham C.U., Smith C.M., Beauchamp A.S., Leung P.W., Turner C.P. Neonatal exposure to MK801 induces structural reorganization of the central nervous system. Neuroreport 2006, 17:779-783.
29. Liang X., Wu L., Hand T., Andreasson K. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem 2005, 92:477-486.
30. Liu L.T., Xu Y., Tang P. Mechanistic insights into xenon inhibition of NMDA receptors from MD simulations. J Phys Chem B 2010, 114:9010-9016.
31. Lu L.X., Yon J.H., Carter L.B., Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 2006, 11:1603-1615.
32. Lyall A., Swanson J., Liu C., Blumenthal T.D., Turner C.P. Neonatal exposure to MK801 promotes prepulse-induced delay in startle response time in adult rats. Exp Brain Res 2009, 197:215-222.
33. Matsushima K., Hakim A.M. Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion. Stroke 1995, 26:1047-1052.
34. Naveilhan P., Neveu I., Baudet C., Funakoshi H., Wion D., Brachet P., Metsis M. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res Mol Brain Res 1996, 41:259-268.
35. Neveu I., Naveilhan P., Baudet C., Brachet P., Metsis M. 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 1994, 6:124-126.
36. Pascual M., Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J Neurochem 2007, 103:557-568.
37. Quinn R. Comparing rat's to human's age: how old is my rat in people years?. Nutrition 2005, 21:775-777.
38. Ringler S.L., Aye J., Byrne E., Anderson M., Turner C.P. Effects of disrupting calcium homeostasis on neuronal maturation: early inhibition and later recovery. Cell Mol Neurobiol 2008, 28:389-409.
39. Rosomoff H.L. Protective effects of hypothermia against pathological processes of the nervous system. Ann N Y Acad Sci 1959, 80:475-486.
40. Shimazawa M., Tanaka H., Ito Y., Morimoto N., Tsuruma K., Kadokura M., Tamura S., Inoue T., Yamada M., Takahashi H., Warita H., Aoki M., Hara H. An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS One 2010, 5:e15307.
41. Sokolowska P., Passemard S., Mok A., Schwendimann L., Gozes I., Gressens P. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy. Neuroscience 2011, 173:156-168.
42. Soliman A.T., El-Dabbagh M., Adel A., Al Ali M., Aziz Bedair E.M., Elalaily R.K. Clinical responses to a mega-dose of vitamin D3 in infants and toddlers with vitamin D deficiency rickets. J Trop Pediatr 2010, 56:19-26.
43. Steen P.A., Soule E.H., Michenfelder J.D. Deterimental effect of prolonged hypothermia in cats and monkeys with and without regional cerebral ischemia. Stroke 1979, 10:522-529.
44. Strauss K.I. COX2 inhibitors for acquired brain injuries: is the time ripe?. Crit Care Med 2010, 38:723-724.
45. Todd M.M. Anesthetic neurotoxicity: the collision between laboratory neuroscience and clinical medicine. Anesthesiology 2004, 101:272-273.
46. Turner C.P., Debenedetto D., Liu C. NMDAR blockade-induced neonatal brain injury: reversal by the calcium channel agonist BayK 8644. Neurosci Lett 2009, 450:292-295.
47. Turner C.P., Debenedetto D., Walburg C., Ware E., Lambert A., Lee A., Swanson J., Stowe R., Lyle M., Desai P., Johnson R., Liu C. MK801-induced activated caspase-3 exhibits selective co-localization with GAD67. Neurosci Lett 2009, 462:152-156.
48. Turner C.P., Debenedetto D., Ware E., Stowe R., Lee A., Swanson J., Walburg C., Lambert A., Lyle M., Desai P., Liu C. Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin. Exp Brain Res 2010, 201(3):479-488.
49. Turner C.P., Connell J., Blackstone K., Ringler S.L. Loss of calcium and increased apoptosis within the same neuron. Brain Res 2007, 1128:50-60.
50. Turner C.P., Miller R., Smith C., Brown L., Blackstone K., Dunham S.R., Strehlow R., Manfredi M., Slocum P., Iverson K., West M., Ringler S.L., Berry Z.C. Widespread neonatal brain damage following calcium channel blockade. Dev Neurosci 2007, 29:213-231.
51. Turner C.P., Pulciani D., Rivkees S.A. Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 2002, 178:21-32.
52. Turner C.P. Perfect storm in a baby's brain. Annual Society for Neurosscience Meeting, Chicago 2009, 39:413.10.
53. Wilder R.T., Flick R.P., Sprung J., Katusic S.K., Barbaresi W.J., Mickelson C., Gleich S.J., Schroeder D.R., Weaver A.L., Warner D.O. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009, 110:796-804.
54. Yon J.H., Carter L.B., Reiter R.J., Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006, 21:522-530.
55. Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E., Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C., Brenneman D.E., Gozes I. Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem 2001, 276:708-714.
56. Zemlyak I., Furman S., Brenneman D.E., Gozes I. A novel peptide prevents death in enriched neuronal cultures. Regul Pept 2000, 96:39-43.
57. Zemlyak I., Manley N., Sapolsky R., Gozes I. NAP protects hippocampal neurons against multiple toxins. Peptides 2007, 28:2004-2008.
58. Zemlyak I., Manley N., Vulih-Shultzman I., Cutler A.B., Graber K., Sapolsky R.M., Gozes I. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. J Neurochem 2009, 111:1252-1263.
59. Zemlyak I., Sapolsky R., Gozes I. NAP protects against cyanide-related microtubule destruction. J Neural Transm 2009, 116:1411-1416.
60. Zemlyak I., Sapolsky R., Gozes I. NAP protects against cytochrome c release: inhibition of the initiation of apoptosis. Eur J Pharmacol 2009, 618:9-14.
61. Zheng Z., Schwab S., Grau A., Berger C. Neuroprotection by early and delayed treatment of acute stroke with high dose aspirin. Brain Res 2007, 1186:275-280.